DCUN1D1 and neddylation: Potential targets for cancer therapy

接合作用 癌症治疗 癌症 医学 计算生物学 癌症研究 肿瘤科 生物 内科学 泛素 遗传学 泛素连接酶 基因
作者
Juliano D. Paccez,Chiara L.M. Foret,Jaira F. de Vasconcellos,Lara Donaldson,Luiz F. Zerbini
出处
期刊:Biochimica Et Biophysica Acta: Molecular Basis Of Disease [Elsevier]
卷期号:1870 (7): 167308-167308
标识
DOI:10.1016/j.bbadis.2024.167308
摘要

Cancer affects millions of people and understanding the molecular mechanisms related to disease development and progression is essential to manage the disease. Post-translational modification (PTM) processes such as ubiquitination and neddylation have a significant role in cancer development and progression by regulating protein stability, function, and interaction with other biomolecules. Both ubiquitination and neddylation are analogous processes that involves a series of enzymatic steps leading to the covalent attachment of ubiquitin or NEDD8 to target proteins. Neddylation modifies the CRL family of E3 ligase and regulates target proteins' function and stability. The DCUN1D1 protein is a regulator of protein neddylation and ubiquitination and acts promoting the neddylation of the cullin family components of E3-CRL complexes and is known to be upregulated in several types of cancers. In this review we compare the PTM ubiquitination and neddylation. Our discussion is focused on the neddylation process and the role of DCUN1D1 protein in cancer development. Furthermore, we provide describe DCUN1D1 protein and discuss its role in pathogenesis and signalling pathway in six different types of cancer. Additionally, we explore both the neddylation and DCUN1D1 pathways as potential druggable targets for therapeutic interventions. We focus our analysis on the development of compounds that target specifically neddylation or DCUN1D1. Finally, we provide a critical analysis about the challenges and perspectives in the field of DCUN1D1 and neddylation in cancer research. Neddylation is a post-translational modification that regulates target proteins' function and stability. One regulator of the neddylation process is a protein named DCUN1D1 and it is known to have its expression deregulated in several types of cancers. Here, we provide a detailed description of DCUN1D1 structure and its consequence for the development of cancer. We discuss both the neddylation and DCUN1D1 pathways as potential druggable targets for therapeutic interventions and provide a critical analysis about the challenges and perspectives in the field of DCUN1D1 and neddylation in cancer research.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
云宇发布了新的文献求助10
1秒前
Progie应助韭菜采纳,获得10
2秒前
追寻紫安应助韭菜采纳,获得10
2秒前
科研通AI2S应助韭菜采纳,获得10
2秒前
清脆慕山发布了新的文献求助10
2秒前
科研通AI2S应助隐形之玉采纳,获得30
2秒前
3秒前
高手中的糕手完成签到,获得积分10
3秒前
可靠的冰烟完成签到,获得积分10
3秒前
九妹完成签到,获得积分10
3秒前
Phosphene应助暴躁的问兰采纳,获得10
4秒前
不配.应助ZR采纳,获得20
4秒前
嘘唏发布了新的文献求助20
5秒前
xfy完成签到,获得积分10
5秒前
852应助汎影采纳,获得10
7秒前
123完成签到,获得积分10
7秒前
不配.应助LIKO采纳,获得20
7秒前
兔兔要睡觉完成签到 ,获得积分10
8秒前
陆安完成签到 ,获得积分10
8秒前
滴滴滴完成签到,获得积分10
8秒前
9秒前
王建平完成签到,获得积分10
9秒前
CodeCraft应助张瑞雪采纳,获得10
10秒前
李龙龙完成签到,获得积分10
10秒前
11秒前
削菠萝发布了新的文献求助10
11秒前
云宇完成签到,获得积分10
12秒前
木木完成签到,获得积分20
13秒前
13秒前
beleve发布了新的文献求助10
13秒前
闾丘惜萱发布了新的文献求助10
14秒前
14秒前
兔兔不睡觉完成签到 ,获得积分10
15秒前
15秒前
橘子果酱完成签到,获得积分10
16秒前
16秒前
星辰大海应助汎影采纳,获得10
16秒前
18秒前
hudu完成签到,获得积分10
18秒前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3138252
求助须知:如何正确求助?哪些是违规求助? 2789208
关于积分的说明 7790538
捐赠科研通 2445551
什么是DOI,文献DOI怎么找? 1300565
科研通“疑难数据库(出版商)”最低求助积分说明 625925
版权声明 601053